| Primary |
| Benign Prostatic Hyperplasia |
18.7% |
| Product Used For Unknown Indication |
11.9% |
| Drug Use For Unknown Indication |
9.0% |
| Hypertension |
9.0% |
| Sciatica |
9.0% |
| Diabetes Mellitus |
5.2% |
| Insomnia |
5.2% |
| Constipation |
4.5% |
| Gastritis Prophylaxis |
4.5% |
| Nasopharyngitis |
4.5% |
| Tinea Cruris |
4.5% |
| Eczema |
3.0% |
| Pain |
2.2% |
| Pollakiuria |
2.2% |
| Bladder Disorder |
1.5% |
| Urine Flow Decreased |
1.5% |
| Ventricular Extrasystoles |
1.5% |
| Arrhythmia |
0.7% |
| Atrial Fibrillation |
0.7% |
| Blood Pressure |
0.7% |
|
| Cerebral Haemorrhage |
13.9% |
| Product Substitution Issue |
8.3% |
| Sudden Death |
8.3% |
| Tremor |
8.3% |
| Cholelithiasis Obstructive |
5.6% |
| Diplopia |
5.6% |
| Off Label Use |
5.6% |
| Retrograde Ejaculation |
5.6% |
| Syncope |
5.6% |
| Vomiting |
5.6% |
| Colon Cancer Metastatic |
2.8% |
| Drug Interaction |
2.8% |
| Eye Haemorrhage |
2.8% |
| Hyperglycaemia |
2.8% |
| Hyperhidrosis |
2.8% |
| Hypotension |
2.8% |
| Incorrect Storage Of Drug |
2.8% |
| Iris Disorder |
2.8% |
| Large Intestine Carcinoma |
2.8% |
| Migraine |
2.8% |
|
| Secondary |
| Product Used For Unknown Indication |
20.8% |
| Hypertension |
18.2% |
| Benign Prostatic Hyperplasia |
9.4% |
| Pain |
7.5% |
| Neuralgia |
5.7% |
| Drug Use For Unknown Indication |
4.4% |
| Insomnia |
3.8% |
| Prostatic Adenoma |
3.8% |
| Type 2 Diabetes Mellitus |
3.8% |
| Cardiac Failure |
3.1% |
| Delirium |
2.5% |
| Arrhythmia |
1.9% |
| Cellulitis |
1.9% |
| Diabetes Mellitus |
1.9% |
| Epilepsy |
1.9% |
| Folate Deficiency |
1.9% |
| Hypothyroidism |
1.9% |
| Infection |
1.9% |
| Platelet Aggregation Inhibition |
1.9% |
| Procedural Pain |
1.9% |
|
| Cardiac Failure |
10.0% |
| Renal Impairment |
10.0% |
| Tendonitis |
10.0% |
| Hepatocellular Injury |
6.7% |
| Hypoaesthesia |
6.7% |
| Orthostatic Hypotension |
6.7% |
| Trigger Finger |
6.7% |
| Cerebral Haemorrhage |
3.3% |
| Cholestasis |
3.3% |
| Convulsion |
3.3% |
| Dehydration |
3.3% |
| Drug Ineffective |
3.3% |
| Hypovolaemia |
3.3% |
| Jaundice Cholestatic |
3.3% |
| Loss Of Consciousness |
3.3% |
| Multiple Fractures |
3.3% |
| Off Label Use |
3.3% |
| Pneumonia |
3.3% |
| Presyncope |
3.3% |
| Pruritus |
3.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
43.1% |
| Hypertension |
8.1% |
| Prostate Cancer |
7.8% |
| Drug Use For Unknown Indication |
5.0% |
| Benign Prostatic Hyperplasia |
4.0% |
| Prostatic Disorder |
4.0% |
| Diabetes Mellitus |
3.4% |
| Pain |
3.4% |
| Urinary Retention |
2.4% |
| Depression |
2.1% |
| Atrial Fibrillation |
2.0% |
| Nausea |
2.0% |
| Hypercholesterolaemia |
1.8% |
| Nasopharyngitis |
1.8% |
| Non-small Cell Lung Cancer |
1.7% |
| Constipation |
1.6% |
| Insomnia |
1.6% |
| Renal Transplant |
1.6% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Rheumatoid Arthritis |
1.3% |
|
| Tremor |
11.0% |
| Swelling Face |
7.7% |
| Drug Ineffective |
6.6% |
| Subdural Haemorrhage |
6.6% |
| Fall |
5.5% |
| Hypoglycaemia |
5.5% |
| Prostatic Disorder |
5.5% |
| Acute Myocardial Infarction |
4.4% |
| Arthralgia |
4.4% |
| Headache |
4.4% |
| Off Label Use |
4.4% |
| Spinal Osteoarthritis |
4.4% |
| Thrombocytopenia |
4.4% |
| Vitreous Opacities |
4.4% |
| Vomiting |
4.4% |
| Diarrhoea |
3.3% |
| Drug Interaction |
3.3% |
| Liver Injury |
3.3% |
| Malaise |
3.3% |
| Myalgia |
3.3% |
|
| Interacting |
| Circadian Rhythm Sleep Disorder |
22.2% |
| Coronary Artery Disease |
22.2% |
| Pollakiuria |
22.2% |
| Prostatic Disorder |
22.2% |
| Insomnia |
11.1% |
|
| Restlessness |
40.0% |
| Drug Interaction |
20.0% |
| Hypotension |
20.0% |
| Sudden Death |
20.0% |
|
